Our goal is to rapidly develop internationally competitive retinal implants and technologies that are shown to be clinically safe and effective in restoring sight, leading to successful commercialisation.
We are developing two devices simultaneously:
In addition to developing the hardware for these devices, our researchers are:
- designing strategies to electrically stimulate the remaining cells in the retina so visual information can be passed along the visual pathway to the brain
- establishing the safety and efficacy of both devices
- developing pre- and post-operative procedures for assessing patients
- developing safe and reproducible surgical procedures for implanting these devices into patients.
We have begun patient tests of a 24-electrode prototype with three people in Melbourne. We hope to begin further patient tests in 2014.
We are developing the High-Acuity device in parallel with the Wide-View device.